Product Information
FLUOXETINE HCL 20 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0964 per EA under NDC 68180099906. Its NADAC has been published 332 times since Oct 16, 2019.
FDA first approved this application on Apr 15, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180099906
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211653FDA Approved
4/15/2019
TE Code
AB
On Market Since
8/7/2019
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 20 MG TABLET has been published 332 times since Oct 16, 2019, and over the history we have for it it has declined 84.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0964 per EA |
|---|---|
| All-time high | $0.6808 (Feb 12, 2020) |
| All-time low | $0.0653 (Nov 20, 2024) |
| 52-week high | $0.1237 |
| 52-week low | $0.0883 |
| Median price | $0.2005 |
| Average price | $0.2416 |
| Largest weekly change | +51.8% (Nov 22, 2023) |
| Weeks tracked | 332 |
| Tracking since | Oct 16, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-22.1%
3Y
-32.6%
5Y
-60.9%
All
-84.9%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 20 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0964 per EA (NDC 68180099906), effective Feb 18, 2026.
How has the price of FLUOXETINE HCL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 20 MG TABLET has declined 84.9%. It has been tracked across 332 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 20 MG TABLET?
Since Oct 16, 2019, the NADAC for FLUOXETINE HCL 20 MG TABLET has ranged from a low of $0.0653 (Nov 20, 2024) to a high of $0.6808 (Feb 12, 2020), with a median of $0.2005 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 20 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOXETINE HCL 20 MG TABLET, is $0.0883 per EA — about 8% below FLUOXETINE HCL 20 MG TABLET.
Who manufactures FLUOXETINE HCL 20 MG TABLET?
FLUOXETINE HCL 20 MG TABLET (NDC 68180099906) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.